Trial · NCT07891546
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Mean Total Score Treatment Credibility | After session 1 of intervention (one week after baseline) | 2-item self-report measure of participant's belief regarding how helpful the intervention will be for them. Higher scores (min = 0, max = 4) scores indicate greater credibility. |
| Primary | Mean Total Score Client Satisfaction Questionnaire | Post-intervention (week 6) | 3-item self-report measure assessing patient satisfaction with the program. Higher total scores (min = 3, max = 12) indicate greater satisfaction. |
| Primary | Percentage of Eligible Participants Enrolled | Post-intervention (week 6) | Percentage of eligible approached individuals that are enrolled into the study. |
| Primary | Percentage of Participants with Missing Data | 1-month follow-up (week 10) | Percentage of all participants with no measure fully missing at follow-up. |
| Primary | Attendance Rate | Post-intervention (week 6) | Percentage of participants completing 6/8 sessions of the intervention. |
| Primary | Number of Adverse Events | 1-month follow-up (week 10) | Number of adverse events related to participation in the study. |
| Secondary | Patient Health Questionnaire-9 | pre-intervention (week 0); post-intervention (week 6); 1 month follow-up (week 10) | 9-item self-report measure of depression symptoms. Higher scores (min=0, max=27) indicate greater depressive symptoms. |
| Secondary | Selection, Optimization, and Compensation (SOC) in Everyday Use | pre-intervention (week 0); post-intervention (week 6); 1 month follow-up (week 10) | 4-item self-report measure of the application of selection, optimization, and compensation strategies in daily life. Items are averaged for a composite score, with higher scores indicate greater SOC strategy use (Range = 1-6). |
| Secondary | PROMIS Short Form v1.0 - Self-Efficacy for Managing Emotions 4a | pre-intervention (week 0); post-intervention (week 6); 1 month follow-up (week 10) | 4-item self-report measure of ability to manage difficult emotions. Higher scores indicate greater use and effectiveness of emotional regulation skills; raw scores will be converted to T-scores (normed, M=50, SD=10). |
| Secondary | PROMIS Global Mental Health-4 | pre-intervention (week 0); post-intervention (week 6); 1 month follow-up (week 10) | 4-item self report of overall emotional wellbeing. Raw scores are converted to T-scores (normed, M=50, SD=10) |
| Secondary | Euro QoL-5D 5L | pre-intervention (week 0); post-intervention (week 6); 1 month follow-up (week 10) | 6-item self-report measure of subjective health-related quality of life. Higher scores indicate worse health-related quality of life (Range = 5-25). The scale also includes a separately scored single-item global health indicator, asked on a 0-100 scale with higher scores indicate higher subjective health-related quality of life. |
| Secondary | CoreQ | Post-intervention (week 6) | 4-item self-report of nursing facility satisfaction. Higher averaged scores indicate greater facility satisfaction (Range = 1-5). |
| Secondary | University of Washington Resilience Scale Short Form | pre-intervention (week 0); post-intervention (week 6); 1 month follow-up (week 10) | 4-item self-report of an individual's perceived resilience. Summed scores will be converted to T-scores using a conversion table. |
| Secondary | Psychotropic medication use | pre-intervention (week 0); post-intervention (week 6); 1 month follow-up (week 10) | Chart or self reported psychotropic medication use. Patients will self-report changes to medication, including dosage, at post-intervention and follow-up |
| Secondary | Re-hospitalization | post-intervention (week 6); 1 month follow-up (week 10) | Resident re-hospitalization during the study period |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07891546/registered